Global Neurotechnology Market Size, Share, Trends, Growth: By Product Type: Imaging Modalities, Neurostimulation, Neurological Implants; By Condition: Parkinson's Disease, Epilepsy, Pain Treatment, Essential Tremor, Sleep Disorder, Hearing Conditions, Other Conditions; By End Use; Regional Analysis; Supplier Landscape; 2024-2032

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Neurotechnology Market Overview 
    3.1    Global Neurotechnology Market Historical Value (2017-2023) 
    3.2    Global Neurotechnology Market Forecast Value (2024-2032)
4    Vendor Positioning Analysis
    4.1    Key Vendors
    4.2    Prospective Leaders
    4.3    Niche Leaders
    4.4    Disruptors
5    Global Neurotechnology Market Landscape*
    5.1    Global Neurotechnology: Developers Landscape
        5.1.1    Analysis by Year of Establishment
        5.1.2    Analysis by Company Size
        5.1.3    Analysis by Region
    5.2    Global Neurotechnology: Product Landscape 
        5.2.1    Analysis by Product Type
6    Global Neurotechnology Market Dynamics
    6.1    Market Drivers and Constraints
    6.2    SWOT Analysis
        6.2.1    Strengths
        6.2.2    Weaknesses
        6.2.3    Opportunities
        6.2.4    Threats
    6.3    PESTEL Analysis
        6.3.1    Political
        6.3.2    Economic
        6.3.3    Social
        6.3.4    Technological
        6.3.5    Legal
        6.3.6    Environment
    6.4    Porter’s Five Forces Model
        6.4.1    Bargaining Power of Suppliers
        6.4.2    Bargaining Power of Buyers
        6.4.3    Threat of New Entrants
        6.4.4    Threat of Substitutes
        6.4.5    Degree of Rivalry
    6.5    Key Demand Indicators 
    6.6    Key Price Indicators
    6.7    Industry Events, Initiatives, and Trends  
    6.8    Value Chain Analysis
7    Global Neurotechnology Market Segmentation (2017-2032)
    7.1    Global Neurotechnology Market (2017-2032) by Product Type
        7.1.1    Market Overview
        7.1.2    Imaging Modalities
            7.1.2.1    Functional Imaging
            7.1.2.2    Structural Imaging
        7.1.3    Neurostimulation
        7.1.4    Neurological Implants
    7.2    Global Neurotechnology Market (2017-2032) by Condition
        7.2.1    Market Overview
        7.2.2    Parkinson's Disease
        7.2.3    Epilepsy 
        7.2.4    Pain Treatment
        7.2.5    Essential Tremor
        7.2.6    Sleep Disorder
        7.2.7    Hearing Conditions
        7.2.8    Other Conditions
    7.3    Global Neurotechnology Market (2017-2032) by End Use
        7.3.1    Market Overview
        7.3.2    Hospitals
        7.3.3    Clinics
        7.3.4    Diagnostic Centres
        7.3.5    Ambulatory Surgical Centres
    7.4    Global Neurotechnology Market (2017-2032) by Region
        7.4.1    Market Overview
        7.4.2    North America
        7.4.3    Europe 
        7.4.4    Asia Pacific
        7.4.5    Latin America
        7.4.6    Middle East and Africa
8    North America Neurotechnology Market (2017-2032)
    8.1    North America Neurotechnology Market (2017-2032) by Product Type
        8.1.1    Market Overview
        8.1.2    Imaging Modalities
            8.1.2.1    Functional Imaging
            8.1.2.2    Structural Imaging
        8.1.3    Neurostimulation
        8.1.4    Neurological Implants
    8.2    North America Neurotechnology Market (2017-2032) by Condition
        8.2.1    Market Overview
        8.2.2    Parkinson's Disease
        8.2.3    Epilepsy 
        8.2.4    Pain Treatment
        8.2.5    Essential Tremor
        8.2.6    Sleep Disorder
        8.2.7    Hearing Conditions
        8.2.8    Other Conditions
    8.3    North America Neurotechnology Market (2017-2032) by Country
        8.3.1    United States of America
        8.3.2    Canada
9    Europe Neurotechnology Market (2017-2032)
    9.1    Europe Neurotechnology Market (2017-2032) by Product Type
        9.1.1    Market Overview
        9.1.2    Imaging Modalities
            9.1.2.1    Functional Imaging
            9.1.2.2    Structural Imaging
        9.1.3    Neurostimulation
        9.1.4    Neurological Implants
    9.2    Europe Neurotechnology Market (2017-2032) by Condition
        9.2.1    Market Overview
        9.2.2    Parkinson's Disease
        9.2.3    Epilepsy 
        9.2.4    Pain Treatment
        9.2.5    Essential Tremor
        9.2.6    Sleep Disorder
        9.2.7    Hearing Conditions
        9.2.8    Other Conditions
    9.3    Europe Neurotechnology Market (2017-2032) by Country
        9.3.1    United Kingdom
        9.3.2    Germany
        9.3.3    France
        9.3.4    Italy
        9.3.5    Others
10    Asia Pacific Neurotechnology Market (2017-2032)
    10.1    Asia Pacific Neurotechnology Market (2017-2032) by Product Type
        10.1.1    Market Overview
        10.1.2    Imaging Modalities
            10.1.2.1    Functional Imaging
            10.1.2.2    Structural Imaging
        10.1.3    Neurostimulation
        10.1.4    Neurological Implants
    10.2    Asia Pacific Neurotechnology Market (2017-2032) by Condition
        10.2.1    Market Overview
        10.2.2    Parkinson's Disease
        10.2.3    Epilepsy 
        10.2.4    Pain Treatment
        10.2.5    Essential Tremor
        10.2.6    Sleep Disorder
        10.2.7    Hearing Conditions
        10.2.8    Other Conditions
    10.3    Asia Pacific Neurotechnology Market (2017-2032) by Country
        10.3.1    China
        10.3.2    Japan
        10.3.3    India
        10.3.4    ASEAN
        10.3.5    Australia
        10.3.6    Others
11    Latin America Neurotechnology Market (2017-2032)
    11.1    Latin America Neurotechnology Market (2017-2032) by Product Type
        11.1.1    Market Overview
        11.1.2    Imaging Modalities
            11.1.2.1    Functional Imaging
            11.1.2.2    Structural Imaging
        11.1.3    Neurostimulation
        11.1.4    Neurological Implants
    11.2    Latin America Neurotechnology Market (2017-2032) by Condition
        11.2.1    Market Overview
        11.2.2    Parkinson's Disease
        11.2.3    Epilepsy 
        11.2.4    Pain Treatment
        11.2.5    Essential Tremor
        11.2.6    Sleep Disorder
        11.2.7    Hearing Conditions
        11.2.8    Other Conditions
    11.3    Latin America Neurotechnology Market (2017-2032) by Country
        11.3.1    Brazil
        11.3.2    Argentina
        11.3.3    Mexico
        11.3.4    Others
12    Middle East and  Africa Neurotechnology Market (2017-2032)
    12.1    Middle East and Africa Neurotechnology Market (2017-2032) by Product Type
        12.1.1    Market Overview
        12.1.2    Imaging Modalities
            12.1.2.1    Functional Imaging
            12.1.2.2    Structural Imaging
        12.1.3    Neurostimulation
        12.1.4    Neurological Implants
    12.2    Middle East and Africa Neurotechnology Market (2017-2032) by Condition
        12.2.1    Market Overview
        12.2.2    Parkinson's Disease
        12.2.3    Epilepsy 
        12.2.4    Pain Treatment
        12.2.5    Essential Tremor
        12.2.6    Sleep Disorder
        12.2.7    Hearing Conditions
        12.2.8    Other Conditions
    12.3    Middle East and Africa Neurotechnology Market (2017-2032) by Country
        12.3.1    Saudi Arabia
        12.3.2    United Arab Emirates
        12.3.3    Nigeria
        12.3.4    South Africa
        12.3.5    Others
13    Regulatory Framework
    13.1    Regulatory Overview
    13.2    US FDA
    13.3    EU EMA
    13.4    INDIA CDSCO
    13.5    JAPAN PMDA
    13.6    Others
14    Clinical Trial Analysis
    14.1    Analysis by Trial Registration Year
    14.2     Analysis by Trial Status
    14.3    Analysis by Trial Phase
    14.4    Analysis by Therapeutic Area
    14.5    Analysis by Geography
15    Grant Analysis
    15.1    Analysis by Year
    15.2    Analysis by Amount Awarded
    15.3    Analysis by Issuing Authority
    15.4    Analysis by Grant Product
    15.5    Analysis by Funding Institute
    15.6    Analysis by Departments
    15.7    Analysis by Recipient Organization
16    Strategic  Initiatives
    16.1    Analysis by Partnership Instances
    16.2    Analysis by Type of Partnership and Collaborations
    16.3    Analysis by Joint Ventures
    16.4    Analysis by Leading Players
    16.5    Analysis by Geography 
17    Supplier Landscape
    17.1    Market Share Analysis, By Region (Top 5 Companies)
        17.1.1    Market Share Analysis: Global
        17.1.2    Market Share Analysis: North America
        17.1.3    Market Share Analysis: Europe
        17.1.4    Market Share Analysis: Asia-Pacific
        17.1.5    Market Share Analysis: Others
    17.2    Allengers Medical Systems Ltd
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications 
    17.3    Canon Medical Systems Corporation
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    GE Healthcare Technologies Inc. 
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Koninklijke Philips N.V.
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Natus Medical Incorporated
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Siemens Healthcare GmbH
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    The Magstim Company Limited
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Tristan Technologies Inc. 
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Shimadzu Corporation
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications 
    17.11    Medtronic plc
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
18    Global Neurotechnology Market – Distribution Model (Additional Insight)
    18.1     Overview 
    18.2     Potential Distributors 
    18.3     Key Parameters for Distribution Partner Assessment 

19    Key  Opinion Leaders (KOL) Insights (Additional Insight)

*Additional insights provided are customisable as per client requirements.

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.